›› 2014, Vol. 32 ›› Issue (10): 936-.doi: 10.3969 j.issn.1000-3606.2014.10.010

Previous Articles     Next Articles

Disseminated Staphylococcus aureus infection in children: a clinical analysis of 14 cases

WU Hujun, WEN Shunhang, LIN Li, LIU Liu, GUO Shuzhen, LI Changchong   

  1. Department of Respiratory Medicine, Yuying Children’s Hospital Affiliated to Wenzhou Medical University, Wenzhou, 325027, Zhejiang, China
  • Received:2014-10-15 Online:2014-10-15 Published:2014-10-15

Abstract: Objective To study the disseminated Staphylococcus aureus infection (DSAI) in children. Method Clinical features, treatment and prognosis data of 14 children with DSAI admitted to Yuying Children’s Hospital Affiliated to Wenzhou Medical University from January 2006 to December 2013 was retrospectively reviewed. Results 14 children with DSAI occurred in community, median age: 15m (range 6d–13y); 50% male (7 cases). All patients presented with fever. Addition to fever, the first symptom was skin and soft tissue infections (SSTIs,6 cases) as well as limb and/or joint pain (5 cases). Among children with DSAI, white blood cell count and C-reactive protein values increased significantly. Pyogenic infection site were skin and soft tissue in 12 cases (85.7%), pulmonary (12 cases), bone (4 cases), joint (3 cases), central nervous system (3 case), and pericardium (1 case). SSTIs concurrent with pulmonary infection was found in 10 cases (71.4%). Incision and drainage of skin and soft tissue absc sses were performed in 9 cases, joint debridement and vacuum sealing drainage (VSD) in 3 cases, osteomyelitis debridement and VSD in 3 cases, and closed chest drainage in 3 cases. All cases received vancomycin and/or linezolid treatment, 5 cases supplemented by rifampicin, and intravenous immune globulin therapy was administered in 11 cases. Clinical manifestations were cured or improved in 12 cases (85.7%). Conclusions Clinical diagnosis of DSAI in children needs to be vigilant. SSTIs, bone and joint infections were major precipitating factors. Intravenous immune globulin therapy was supplemented to the application of antibiotics, which might get better clinical outcomes in children.